Dual FGFR-targeting and pH-activatable ruthenium-peptide conjugates for targeted therapy of breast cancer

J.F. Machado, M. Sá, I. Pires, M.T. da Silva, F. Marques, J.A.S. Coelho, F. Mendes, M.F.M. Piedade, M. Machuqueiro, M.A. Jiménez, M.H. Garcia, J.D.G. Correia, T.S. Morais, Dalton Transactions, 2024, 53, 7682. 

DOI: 10.1039/D4DT00497C 

Are smart delivery systems the solution to overcome the lack of selectivity of current metallodrugs in cancer therapy? 

J.F. Machado, T.S. Morais, Dalton Transactions, 2022, 51, 2593-2609.

DOI: 10.1039/D1DT04079K